INTERNATIONAL PATENT: SAREPTA THERAPEUTICS, INC., RENOGENYX, INC. FILES APPLICATION FOR "DEFICIENT CAS-TRANSCRIPTIONAL REPRESSOR FUSIONS FOR REGULATION OF GENE EXPRESSION"

GENEVA, Feb. 24 -- SAREPTA THERAPEUTICS, INC. (215 First StreetCambridge, Massachusetts 02142), RENOGENYX, INC. (450 Sinclair StreetReno, Nevada 89501) filed a patent application (PCT/US2025/042259) for "DEFICIENT CAS-TRANSCRIPTIONAL REPRESSOR FUSIONS FOR REGULATION OF GENE EXPRESSION" on Aug 15, 2025. With publication no. WO/2026/039783, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HIMEDA, Charis L. (450 Sinclair StreetReno, Nevada 89501), KABADI, Ami M. (215 First StreetCambridge, Massachusetts 02142)

Abstract: Disc...